[
    [
        {
            "time": "",
            "original_text": "药明康德现3笔大宗交易，共成交6,143.14万元",
            "features": {
                "keywords": [
                    "药明康德",
                    "大宗交易",
                    "成交"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德现3笔大宗交易，共成交6,143.14万元",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "大和：上调药明康德(02359)目标价36.8%至238港元，评级“跑赢大市”",
            "features": {
                "keywords": [
                    "药明康德",
                    "上调",
                    "目标价",
                    "跑赢大市"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "大和：上调药明康德(02359)目标价36.8%至238港元，评级“跑赢大市”",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "部分明星股日内跌势不止，迈瑞医疗、药明康德、分众传媒均下挫逾7%",
            "features": {
                "keywords": [
                    "明星股",
                    "跌势",
                    "迈瑞医疗",
                    "药明康德",
                    "分众传媒"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "广告传媒"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "部分明星股日内跌势不止，迈瑞医疗、药明康德、分众传媒均下挫逾7%",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医疗健康行业基金4Q分析：四季度医药板块配置环比下降，机构持仓名义集中",
            "features": {
                "keywords": [
                    "医疗健康",
                    "基金",
                    "医药板块",
                    "配置下降",
                    "机构持仓"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医疗健康行业基金4Q分析：四季度医药板块配置环比下降，机构持仓名义集中",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药行业Q42020持仓分析：医药仓位有所回落，核心资产持续加强",
            "features": {
                "keywords": [
                    "医药行业",
                    "持仓分析",
                    "仓位回落",
                    "核心资产"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药行业Q42020持仓分析：医药仓位有所回落，核心资产持续加强",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "“药明系”股价再创新高，市值已突破万亿港元",
            "features": {
                "keywords": [
                    "药明系",
                    "股价新高",
                    "市值突破"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "“药明系”股价再创新高，市值已突破万亿港元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "港股生物医药板块集体下挫，泰格医药跌5.9%，康希诺生物跌5.2%，药明康德跌5.1%，药明生物跌4.8%，百济神州跌4%\n连续下跌",
            "features": {
                "keywords": [
                    "港股",
                    "生物医药",
                    "集体下挫",
                    "泰格医药",
                    "康希诺生物",
                    "药明康德",
                    "药明生物",
                    "百济神州"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "港股生物医药板块集体下挫，泰格医药跌5.9%，康希诺生物跌5.2%，药明康德跌5.1%，药明生物跌4.8%，百济神州跌4%\n连续下跌",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "大和升药明康德(02359-HK)目标价至238港元升去年纯利预测",
            "features": {
                "keywords": [
                    "大和",
                    "药明康德",
                    "目标价",
                    "纯利预测"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "大和升药明康德(02359-HK)目标价至238港元升去年纯利预测",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "更快、更多、更好，下一个创新领域在哪里？| 药明康德全球论坛实录",
            "features": {
                "keywords": [
                    "创新领域",
                    "药明康德",
                    "全球论坛"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "更快、更多、更好，下一个创新领域在哪里？| 药明康德全球论坛实录",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "【山证医药】医药行业周报（20210123）：业绩预告密集发布，持续关注高景气细分领域",
            "features": {
                "keywords": [
                    "山证医药",
                    "医药行业",
                    "周报",
                    "业绩预告",
                    "高景气细分领域"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【山证医药】医药行业周报（20210123）：业绩预告密集发布，持续关注高景气细分领域",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "中信建投五大研究团队复盘2020年四季度公募基金持仓",
            "features": {
                "keywords": [
                    "中信建投",
                    "研究团队",
                    "公募基金",
                    "持仓"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "中信建投五大研究团队复盘2020年四季度公募基金持仓",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        }
    ]
]